A Study to Test BI 764198 in People With a Type of Kidney Disease Called Focal Segmental Glomerulosclerosis

Clinical trial NCT05213624 · COMPLETED

Trial details

NCT number: NCT05213624
Sponsor: Boehringer Ingelheim
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Kidney Disease, Chronic

Start date: 2022-05-03
Primary completion: 2025-01-03
Enrollment: 67

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.